Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 52.20
+1.90 (3.78%)
May 29, 2026, 1:30 PM CST
Formosa Laboratories Market Cap
Formosa Laboratories has a market cap or net worth of 6.28 billion as of May 29, 2026. Its market cap has decreased by -12.27% in one year.
Market Cap
6.28B
Enterprise Value
8.44B
Revenue
4.77B
Ranking
n/a
PE Ratio
18.50
Stock Price
52.20
Market Cap Chart
Since March 2, 2011, Formosa Laboratories's market cap has increased from 5.60B to 6.28B, an increase of 12.10%. That is a compound annual growth rate of 0.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 6.28B | -11.97% |
| Dec 31, 2025 | 7.13B | -13.81% |
| Dec 31, 2024 | 8.27B | -32.55% |
| Dec 29, 2023 | 12.27B | 38.78% |
| Dec 30, 2022 | 8.84B | 21.49% |
| Dec 30, 2021 | 7.28B | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Handa Pharmaceuticals | 11.87B |
| Standard Chemical & Pharmaceutical | 10.97B |
| Alar Pharmaceuticals | 8.18B |
| LIWANLI Innovation | 5.45B |
| Orient Pharma | 5.20B |
| SCI Pharmtech | 4.86B |
| Easywell Biomedicals | 4.14B |
| Orient EuroPharma | 3.85B |